Midweek Takeaway with ValiRx CEO Suzy Dilly

Season 1, Episode 2, Nov 03, 2021, 09:03 PM

The Roast team talk candidly to AIM Listed ValiRx CEO Suzy Dilly about the recent letter of intent to Sub-License VAL 201 to TheoremRx Inc.

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.